The nationwide experiment will initially include around 100,000 volunteers.
Restrictions will remain on transgenic plants, which contain artificially inserted genes from other species.
The Scientist
Most Recent
Mice treated with an immunostimulant had better outcomes when researchers blocked the expression of TNFR2, a compound that helps tumors evade immune attack.
Motivated by his father’s cancer diagnosis, the Francis Crick Institute cancer geneticist has been revealing the ways tumors evolve and why they are so difficult to treat.
In the presence of cytosolic DNA, cancer cells activate antiviral pathways that disguise them as immune cells.
Errors in segregation during cell division can lead to inflammation in daughter cells.
Alterations to a protein involved in breathing may help explain some cases of sudden infant death syndrome, a study finds.
Last year, researchers claimed the gene-editing method had accuracy issues, but a new whole-genome sequencing analysis by the same team finds otherwise.
The drugs’ disruption of the microbiome makes a subsequent flavivirus infection more severe.
A study finds that the vaccine’s effects wear off as a person ages, suggesting a need for booster shots.
For decades, Matthews led two important repositories for fruit fly research: the Bloomington Drosophila Stock Center and FlyBase.
Popular Now
-
The Nutshell Estonia Offers Free Genetic Testing to Residents -
Daily News Human Brain Organoids Thrive in Mouse Brains After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
-
The Nutshell New Ovarian Cancer Vaccine Shows Promise A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
-
Daily News The Second March for Science a Smaller Affair Many cities around the globe, including Washington, DC, saw shrunken crowd sizes, and numerous events turned into rallies rather than processions.
Current Issue
© 1986-2018 The Scientist
